NEW YORK (GenomeWeb News) — Clinical Data late Tuesday reported that fiscal fourth-quarter revenues rose 5 percent and net losses jumped 90 percent year over year.
Total receipts for the three months ended March 31 increased to $15.9 million from $15.1 million in the fiscal fourth quarter of 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.